1 |
Koch HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access system: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998:22;12-6
DOI
ScienceOn
|
2 |
Aitken DR, Catalano R, Minton JP. Central vein access in oncology patients: the 'peel-away' sheath for rapid insertion. J Surg Oncol 1983;22:81-3
DOI
ScienceOn
|
3 |
Salzman MB, Rubin LG. Intravenous catheter related infections. Adv Pediatr Infect Dis 1995;10:337-42
PUBMED
|
4 |
Vlasveld LT, Rodenhuis S, Rutgers EJTh, et al. Catheter related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Onco 1994;20:122-9
|
5 |
Raad II, Luna M, Khalil SM, Costerton JW, Lam C, Bodey GP. The relationship between thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-6
DOI
|
6 |
Bern MM, Lokich JJ, Wallach SR. Very low doses of wafarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 1990;112:423-7
DOI
PUBMED
ScienceOn
|
7 |
Sariego J, Bootorabi B, Matsumoto T, Kerstein M. Major long term complications in 1,422 permanent venous access devices. Am J Surg 1993;165:249-51
DOI
ScienceOn
|
8 |
Barrios CH, Zuke JE, BlaesB, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992;49:474-8
DOI
ScienceOn
|
9 |
Ballarini C, Ceretti AP, Cordovana A, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology 1999;56:97-102
DOI
ScienceOn
|
10 |
Brothers TE, Von Moll LK, Niederhuber JE, Roberts JA, Walker-Andrew S, Ensminger WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988;166:295-301
PUBMED
|
11 |
Hinke DH, Zandt-Stastny DA, Goodman LR, et al. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology 1990;177:353-6
DOI
PUBMED
|